1100 related articles for article (PubMed ID: 22332968)
1. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
4. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
[TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
7. Detection of chromosomal blaCTX-M-15 in Escherichia coli O25b-B2-ST131 isolates from the Kinki region of Japan.
Hirai I; Fukui N; Taguchi M; Yamauchi K; Nakamura T; Okano S; Yamamoto Y
Int J Antimicrob Agents; 2013 Dec; 42(6):500-6. PubMed ID: 24091130
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
[TBL] [Abstract][Full Text] [Related]
11. AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131.
Oteo J; Cercenado E; Cuevas O; Bautista V; Delgado-Iribarren A; Orden B; Pérez-Vázquez M; García-Cobos S; Campos J
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):270-6. PubMed ID: 20462723
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of O25b-ST131 clone among Escherichia coli strains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases.
Giedraitienė A; Vitkauskienė A; Pavilonis A; Patamsytė V; Genel N; Decre D; Arlet G
Infect Dis (Lond); 2017 Feb; 49(2):106-112. PubMed ID: 27563748
[TBL] [Abstract][Full Text] [Related]
13. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents.
Dolejska M; Frolkova P; Florek M; Jamborova I; Purgertova M; Kutilova I; Cizek A; Guenther S; Literak I
J Antimicrob Chemother; 2011 Dec; 66(12):2784-90. PubMed ID: 21954457
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.
Blanc V; Leflon-Guibout V; Blanco J; Haenni M; Madec JY; Rafignon G; Bruno P; Mora A; Lopez C; Dahbi G; Dunais B; Anastay M; Branger C; Moreau R; Pradier C; Nicolas-Chanoine MH
J Antimicrob Chemother; 2014 May; 69(5):1231-7. PubMed ID: 24402502
[TBL] [Abstract][Full Text] [Related]
15. Characterization of blaCTX-M IncFII plasmids and clones of Escherichia coli from pets in France.
Dahmen S; Haenni M; Châtre P; Madec JY
J Antimicrob Chemother; 2013 Dec; 68(12):2797-801. PubMed ID: 23852541
[TBL] [Abstract][Full Text] [Related]
16. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
Ewers C; Grobbel M; Stamm I; Kopp PA; Diehl I; Semmler T; Fruth A; Beutlich J; Guerra B; Wieler LH; Guenther S
J Antimicrob Chemother; 2010 Apr; 65(4):651-60. PubMed ID: 20118165
[TBL] [Abstract][Full Text] [Related]
17. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
Hansen F; Olsen SS; Heltberg O; Justesen US; Fuglsang-Damgaard D; Knudsen JD; Hammerum AM
Microb Drug Resist; 2014 Aug; 20(4):316-24. PubMed ID: 24517383
[TBL] [Abstract][Full Text] [Related]
18. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
Namaei MH; Yousefi M; Ziaee M; Salehabadi A; Ghannadkafi M; Amini E; Askari P
Microb Drug Resist; 2017 Oct; 23(7):879-884. PubMed ID: 28437226
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
20. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
